 | Evolus, Inc. Common Stock | |||
| NGM : EOLS || Location: United States | ||||
$11.98+0.09 (+0.76%) |
0.11 M | 11.72 - 12.08 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.649 M |
| March 15, 2024 | 4.976 M |
| Feb. 29, 2024 | 4.963 M |
| Feb. 15, 2024 | 4.901 M |
| Jan. 31, 2024 | 4.764 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.07 | -0.12 | -75.70% |
| 09/30/2023 | -0.18 | -0.16 | 9.86% |
| 06/30/2023 | -0.20 | -0.19 | 4.19% |
| 03/31/2023 | -0.15 | -0.15 | 0.86% |
| 12/31/2022 | -0.15 | -0.14 | 7.16% |
EOLS Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 61.498M | Shares Float | 38.804M |
| Short Float | 4.649M | Market Cap | 731.21M |
| Institution ownership | 77.11% | Insider ownership | 13.054% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.08 | Forward EPS | 0.16 |